Urgent.News

What's breaking now, across thousands of outlets.

Science

Possible new target for sickle cell disease and beta thalassemia treatment identified

Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin.

Possible new target for sickle cell disease and beta thalassemia treatment identified

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

More from Wednesday 30 September →